Spots Global Cancer Trial Database for Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
Official Title:
Study ID: NCT00318604
Interventions
Study Description
Brief Summary: This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: LeJung Wu, MD, DPhil
Affiliation: Far Eastern Memorial Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
